Repurposing of nitroxoline as a potential anticancer agent against human prostate cancer - a crucial role on AMPK/mTOR signaling pathway and the interplay with Chk2 activationWei‐Ling Chang, Jih‐Hwa Guh|Oncotarget|2015Cited by 49
2‐Phenyl‐5‐(pyrrolidin‐1‐yl)‐1‐(3,4,5‐trimethoxybenzyl)‐1 <i>H</i> ‐benzimidazole, a benzimidazole derivative, inhibits growth of human prostate cancer cells by affecting tubulin and c‐Jun N‐terminal kinaseWei‐Ling Chang, Jih‐Hwa Guh|British Journal of Pharmacology|2010Cited by 28
Reevesioside A, a Cardenolide Glycoside, Induces Anticancer Activity against Human Hormone-Refractory Prostate Cancers through Suppression of c-myc Expression and Induction of G1 Arrest of the Cell CycleWohn‐Jenn Leu, Jih‐Hwa Guh|PLoS ONE|2014Cited by 28
Phosphodiesterase Type 5 Inhibitors Synergize Vincristine in Killing Castration-Resistant Prostate Cancer Through Amplifying Mitotic Arrest SignalingJui‐Ling Hsu, Jih‐Hwa Guh|Frontiers in Oncology|2020Cited by 26
<i>Epi</i>-reevesioside F inhibits Na+/K+-ATPase, causing cytosolic acidification, Bak activation and apoptosis in glioblastomaJui‐Ling Hsu, Jih‐Hwa Guh|Oncotarget|2015Cited by 11